Clinical Trial Update: ReoPro and Retavase to Treat Acute Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ReoPro (abciximab) and Retavase (reteplase) for acute stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ReoPro (abciximab)
• Retavase (reteplase)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Cerebrovascular Accident | Phase 2 | Status: COMPLETED